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cholesterol regulates ROR activity under physiologicalROR: An Orphan Nuclear Receptor
conditions with appropriate biological consequences.on a High-Cholesterol Diet One important aspect of ROR biology may already
address this sticking point. Staggerer (sg/sg) mice,
which contain a mutation of the ROR gene that deletes
the LBD, show an increased susceptibility to atheroscle-
A high-resolution X-ray crystal structure of the retinoic rosis when fed a high-fat diet [3]. These mice have low
acid receptor-related orphan receptor (ROR; NR1F1), levels of apolipoprotein A-I, a key component of HDL
which reveals a molecule of cholesterol within the li- particles that transport cholesterol from peripheral tis-
gand binding pocket, is a breakthrough in functional sues and return it to the liver for disposal. ROR has
analysis of this orphan nuclear receptor. been shown to bind to an enhancer element in the apoli-
poprotein A-I promoter and directly regulate transcrip-
Cholesterol is an important membrane component of all tion of its gene [4]. One could postulate that ROR
mammalian cells and a biosynthetic precursor of the senses cholesterol levels and is involved in homeostatic
corticosteroid and sex steroid hormones. The levels of regulation of cholesterol flux through the body. ROR/
cholesterol in the body must be carefully regulated, as or sg/sg mice also have defects in CNS development,
its deposition as plaques on the insides of major blood bone metabolism, vascular tone, and immune function
vessels is a cause of coronary artery disease. Neutral [2, 5]. It remains to be determined whether these latter
cholesterol is not normally considered to be a signaling phenotypes are also due to defective cholesterol sig-
molecule without oxidation to more polar sterol metabo- naling.
lites or catabolism to steroid hormones. Presented in The second test is that cholesterol must be able to
this issue of Structure, a high-resolution X-ray crystal directly regulate ROR activity. The crystal structure
structure of the ROR ligand binding domain (LBD) shows that the ligand binding pocket is not completely
bound to cholesterol challenges this dogma [1]. filled by the cholesterol molecule. Thirteen ordered wa-
The nuclear receptors (NRs) form a superfamily of ter molecules are clustered around the cholesterol
transcription factors that are characterized by a con- 3-OH. The Novartis group hypothesized that a polar
served DNA binding domain and/or LBD. A number of cholesterol metabolite could bind to ROR with higher
these proteins are hormone receptors for steroids and affinity. Using mass spectroscopy, they showed that
secosteroids, such as estrogens, androgens, corticoste- cholesterol sulfate can displace cholesterol from the
roids, and vitamin D. These ligand-activated transcrip- ligand binding pocket, opening the possibility that the
tion factors couple the rise and fall in the level of their receptor could sense this or other cholesterol metabo-
cognate hormone with a coordinated regulation of gene lites.
expression that leads to a diverse range of physiological The binding of cholesterol (or a cholesterol metabolite)
responses, such as embryonic development, cell prolif- to ROR may regulate receptor activity by two different
eration, or feedback suppression of hormone synthesis. mechanisms. The cholesterol molecule could stabilize
There are 48 candidate NRs within the human ge- a conformation of the receptor that promotes recruit-
nome, the majority of which are orphan receptors that ment of coactivator proteins [6]. The positioning of a
were cloned prior to the identification of a cognate hor- C-terminal  helix, known as AF-2, is intimately involved
mone or ligand. Unlike the steroid hormone receptors, in this process. In the ROR crystal structure, the cho-
many of the orphan NRs are constitutively active tran- lesterol side chain is orientated toward AF-2 but does
scription factors, which hints that they may in some way not directly contact it. Instead, hydrophobic packing
be different from the well-characterized ligand-activated and a hydrogen bond between a tyrosine on AF-2 and
NRs. ROR is one of these constitutively active orphan a histidine on helix 11 hold the C-terminal helix in place.
NRs [2]. Remarkably, when Kallen, Fournier, and col- It is unclear how the cholesterol molecule contributes
leagues expressed the ROR LBD and solved the high- to the folding of the AF-2 helix into its active position.
resolution X-ray crystal structure, they found a small An alternative mechanism for regulation of ROR ac-
organic molecule bound within the ligand pocket [1]. tivity by cholesterol is that its presence within the ligand
Analysis of the protein by mass spectroscopy identified binding pocket is required to stabilize the protein fold.
the compound as the ubiquitous steroid cholesterol. In It appears that the ROR LBD is inherently unstable in
an elegant experiment, the Novartis group showed that the absence of a ligand. The Moras group previously
depleting the cellular level of cholesterol using a combi- reported that the LBD of ROR expressed in E. coli is
nation of a statin and a -cyclodextrin derivative led to stabilized by the presence of stearic acid in the ligand
a reduction in ROR activity in a reporter gene assay. pocket [7]. Notably, the ROR LBD was not stable when
The receptor could then be reactivated by addition of expressed from bacteria, where cholesterol would not
cholesterol or a number of cholesterol analogs, demon- be present, but was stable when expressed in insect
strating that ROR functions as a cholesterol sensor cells. Cholesterol must originate from the culture media
under specific conditions. required for the Baculovirus expression, since its de
So, is ROR a bona fide cholesterol receptor? The novo synthesis cannot occur in insects. However, in
mammalian cells, where the concentration of cholesterolfirst critical test that needs to be satisfied is whether
Structure
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is a relatively high, ROR may be bound to a ligand at
all times. In this context, cholesterol may function as a
structural cofactor for the receptor rather than a hor-
monal ligand. Similar conclusions can be drawn from
analysis of the ultraspiracle or HNF4 structures where
phospholipids and fatty acids, respectively, maintain the
fold of these NR LBDs but do not function as signaling
molecules [8, 9].
To what degree the exchange of cholesterol with polar
cholesterol metabolites regulates ROR activity under
physiological conditions is not answered by the current
study. Despite this lingering question, the identification
of ROR as a cholesterol “receptor” is a major advance
in our understanding of this transcription factor that will
undoubtedly aid its functional analysis as well as the
hunt for pharmacologically active synthetic ligands.
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